Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Regulatory And Financial Squeeze Tightens Around UK IVDs Sector

This article was originally published in Clinica

Executive Summary

Growth in the £800m ($1.2bn) UK IVDs market has been driven in recent years by infectious immunology, immunochemistry and hematology, with clinical chemistry holding back the expansion. Current growth of the overall UK market is of the order of 1-2%. Volume testing has risen, but prices have not grown at the same rate, and in fact have trailed behind the inflation rate.